SCHEMBL5712865

SCHEMBL5712865

Nc1sc2c(c1C(=O)c1ccc(Br)cc1)CCN(C(=O)Nc1ccccc1)C2

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
ADORA1 P30542 4/20 0.49
MAPT P10636 3/20 0.49
KDM4E B2RXH2 1/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
TRPV1 Q8NER1 1/20 0.48
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
GAA P10253 1/20 0.47
HPGD P15428 1/20 0.47
TP53 P04637 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
THRB P10828 2/20 0.45
FAAH O00519 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5712947 0.90 MEN1 (0.62) NPC1RAB9AADORA1MAPTKDM4E
SCHEMBL5712958 0.90 ADORA1 (0.49) NPC1RAB9AADORA1MAPTKDM4E
SCHEMBL5342374 0.79 MAPT (0.63) ADORA1MAPTKDM4EMEN1KMT2A
SCHEMBL13738436 0.77 ADORA1 (0.58) ADORA1MAPTKDM4EMEN1KMT2A
SCHEMBL5712829 0.72 MEN1 (0.77) ADORA1MAPTKDM4EMEN1KMT2A
SCHEMBL5712843 0.72 MEN1 (0.51) ADORA1MAPTKDM4EMEN1KMT2A
SCHEMBL4065123 0.72 MAPT (0.81) ADORA1MAPTKDM4EMEN1KMT2A
SCHEMBL135797 0.71 MAPT (0.59) ADORA1MAPTKDM4EMEN1KMT2A
SCHEMBL6992778 0.71 ADORA1 (0.67) ADORA1MAPTKDM4EMEN1KMT2A
SCHEMBL3768395 0.71 TDP1 (0.74) ADORA1MAPTKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1671973-A2 Allosteric adenosine receptor modulators King Pharmaceuticals Research and Development, Inc. (US) 2006-06-21 EP claimed
EP-1671973-A2 Allosteric adenosine receptor modulators King Pharmaceuticals Research and Development, Inc. (US) 2006-06-21 EP disclosed
EP-1025106-B1 ALLOSTERIC ADENOSINE RECEPTOR MODULATORS KING PHARMACEUTICALS RES & DEV (US) 2006-06-21 EP disclosed
US-6323214-B1 CARDIOVASCULAR DISORDERS, NERVOUS SYSTEM DISORDERS AND ANALGESICS MEDCO RESEARCH, INC 2001-11-27 US disclosed